We thus speculate that Sp1 could contribute to the development of malignant tumors through decreasing CoQ10 biosynthesis by regulating PDSS2. This regulatory axis is of great significance in the biomedical field and is currently under deep investigation in our lab. Here, SP1 is linked to cancer.